bioAffinity Technologies, Inc. Stock Issued
bioAffinity Technologies, Inc. (BIAF) reported Stock Issued of $74.28 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:StockIssued1 · last filed 2026-03-16
- bioAffinity Technologies, Inc. stock issued for fiscal 2024 was $74.28K, a 92.57% decline from fiscal 2023.
- bioAffinity Technologies, Inc. stock issued for fiscal 2023 was $1.00M.
| Period end | Stock Issued 12 month |
|---|---|
| 2024-12-31 | $74.28K 10-K · filed 2026-03-16 |
| 2023-12-31 | $1.00M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |